Mikio Sugimoto

36PUBLICATIONS
82CO-AUTHORS
Molecular targetsPredictive and prognostic markersPharmacogenomicsCancer diagnosisLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 21, 2026
Consensus-Based Development of a Surgical Checklist for Transurethral Resection of Bladder Tumor: An Initiative of the Japanese Society of Urologic Oncology.

|May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.

|Mar 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel.

Takuma Kato, Yoichiro Tohi, Atsushi Takamoto

|Jan 31, 2026
Efficacy of Photodynamic Diagnosis Is Confined to the Low-Risk Subgroup of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched Analysis.

Yohei Abe, Rikiya Taoka, Asuka Kaji

|Jan 29, 2026
Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance (PRIAS)-JAPAN study.

Takuma Kato, Akira Yokomizo, Ryuji Matsumoto

|Dec 26, 2025
Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial.

Rikiya Taoka, Hideo Fukuhara, Makito Miyake

Pageof 6

Frequent Collaborators

15 joint publications

Yoichiro Tohi

11 joint publications

Rikiya Taoka

8 joint publications

Takuma Kato

4 joint publications

Hirohito Naito